WELCOME TO
ExpreS2ion Biotech
INVESTOR SITE
Financial Calendar
- 17/08/23
Half-year report, Q2 2023
- 16/11/23
Interim report, Q3 2023
- 08/02/24
Year-end report, 2023
Latest press releases
Bulletin from the Annual General Meeting of ExpreS2ion Biotech Holding AB held on 24 May 2023
Regulatory pressreleaseHelsingborg, Sweden, 24 May 2023 – The annual general meeting 2023 ("AGM") of ExpreS2ion Biotech Holding AB ("ExpreS2ion" or the "Company") was held today, 24 May 2023, in Helsinborg, Sweden.
Read moreExpreS2ion announces financial results for the first quarter 2023
Regulatory pressreleaseHørsholm, Denmark, 16 May 2023– ExpreS2ion Biotech Holding AB (“ExpreS2ion”) today announces its first quarter financial results for 2023. The report is available as an attachment and on ExpreS2ion's website (www.expres2ionbio.com). Below is a summary of the report.
Read more